Page 308 - Biodegradable Polyesters
P. 308

286  11  Electrospun Biopolymer Nanofibers and Their Composites for Drug Delivery Applications

                    drug in pH = 7 simulated gastric fluid, indicating that the nonmetallic concentric
                    spinneret could be exploited to conduct coaxial electrospinning and facilitate the
                    smooth and continuous preparation of electrospun core–sheath nanofibers for
                    providing biphasic drug release profiles [65].

                    11.3.2
                    Emulsion Electrospun Drug/Biopolymer Nanofibers

                    While coaxial electrospinning predominately relies on the complexity in designing
                    and controlling of the electrohydrodynamic process for production of biodegrad-
                    able core–shell structures, an alternative process based on the emulsion electro-
                    spinning technique can produce distinct kind of scaffold in order to promote a
                    better control of release kinetics. In emulsion electrospinning, the drug or aque-
                    ous protein solution is emulsified within a polymer solution referred to as the oil
                    phase, which can be produced into nanofibers containing uniformly distributed
                    low-molecular-weight drugs or with core–shell fibrous structures [66–68].
                      RHB and BSA were successfully incorporated into nanofibers by means of
                    emulsion electrospinning to form composite nanofibrous mats [69]. In vitro dual
                    drug release behaviors indicated that the incorporated drug and/or proteins in
                    composite fibrous mats made from electrospinning could be controllably released
                    by adjusting the processes of emulsion preparation. Xu et al. investigated the
                    release behavior of a water-soluble anticancer agent, DOX, from the drug-loaded
                    nanofibers prepared by emulsion electrospinning [70]. The laser scanning
                    confocal microscopic images indicated that the drug was well incorporated into
                    amphiphilic PEG–PLLA diblock copolymer nanofibers, forming core–sheath
                    structured drug-loaded nanofibers. The drug release behavior showed a three-
                    stage diffusion-controlled mechanism, in which the release rate of the first stage
                    was slower than that of the second stage, but both obeyed Fick’s second law. On
                    the basis of these results, it is concluded that DOX-loaded fibers prepared by
                    emulsion electrospinning represent a reservoir-type delivery system in which
                    DOX release rate decreases with increasing DOX content in the fibers.
                      In drug therapy, most therapeutic drugs are of low molecular weight and could
                    freely diffuse in biological environment depending on the applied administration
                    route. The main reason for the development of polymeric drug carriers is to
                    obtain desired effects such as sustained therapy, local and controlled release,
                    prolonged activity, and reduction of side effects. Alternatively, polymeric carriers
                    can be made biodegradable in order to be eliminated by natural ways after a
                    certain time of therapy. Core–shell fibers from coaxial spinneret or emulsion
                    electrospinning are good candidates for the development of such devices.
                    However, difficulties remain especially in controlling the release over a sustained
                    period.
                      A novel technique combining coaxial and emulsion electrospinning was pre-
                    sented to produce microstructured core–shell fibers. The design of micro drug
                    reservoirs of variable size within the bulk of fibers combined with a tailored dif-
                    fusive barrier allows modulating the release kinetics of these novel carriers. A
   303   304   305   306   307   308   309   310   311   312   313